journal article·2018-07

Aggrecan-like biomimetic proteoglycans (BPGs) composed of natural chondroitin sulfate bristles grafted onto a poly(acrylic acid) core for molecular engineering of the extracellular matrix

K. Prudnikova, S.E. Lightfoot Vidal, S. Sarkar, T. Yu, R.W. Yucha, N. Ganesh, L.S. Penn, L. Han, C.L. Schauer, E.J. Vresilovic, M.S. Marcolongo

Acta Biomaterialia· Volume 75
Publisher page

Abstract

Biomimetic proteoglycans (BPGs) were designed to mimic the three-dimensional (3D) bottlebrush architecture of natural extracellular matrix (ECM) proteoglycans, such as aggrecan. BPGs were synthesized by grafting native chondroitin sulfate bristles onto a synthetic poly(acrylic acid) core to form BPGs at a molecular weight of approximately ∼1.6 MDa. The aggrecan mimics were characterized chemically, physically, and structurally, confirming the 3D bottlebrush architecture as well as a level of water uptake, which is greater than that of the natural proteoglycan, aggrecan. Aggrecan mimics were cytocompatible at physiological concentrations. Fluorescently labeled BPGs were injected into the nucleus pulposus of the intervertebral disc ex vivo and were retained in tissue before and after static loading and equilibrium conditioning. BPGs infiltrated the tissue, distributed and integrated with the ECM on a molecular scale, in the absence of a bolus, thus demonstrating a new molecular approach to tissue repair: molecular matrix engineering. Molecular matrix engineering may compliment or offer an acellular alternative to current regenerative medicine strategies. Statement of significance Aggrecan is a natural biomolecule that is essential for connective tissue hydration and mechanics. Aggrecan is composed of negatively charged chondroitin sulfate bristles attached to a protein core in a bottlebrush configuration. With age and degeneration, enzymatic degradation of aggrecan outpaces cellular synthesis resulting in a loss of this important molecule. We demonstrate a novel biomimetic molecule composed of natural chondroitin sulfate bristles grafted onto an enzymatically-resistant synthetic core. Our molecule mimics a 3D architecture and charge density of the natural aggrecan, can be delivered via a simple injection and is retained in tissue after equilibrium conditioning and loading. This novel material can serve as a platform for molecular repair, drug delivery and tissue engineering in regenerative medicine approaches.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Proteoglycans and glycosaminoglycans research · Hydrogels: synthesis, properties, applications · Spine and Intervertebral Disc Pathology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (70)

Show source-provided references
1. Structure and function of aggrecan10.1038/sj.cr.7290106 ↗
2. Proteoglycans: many forms and many functions10.1096/fasebj.6.3.1740236 ↗
3. Individual cartilage aggrecan macromolecules and their constituent glycosaminoglycans visualized via atomic force microscopy10.1016/j.jsb.2003.08.006 ↗
4. The different roles of aggrecan interaction domains10.1369/0022155412464376 ↗
5. Molecular approach to the understanding of osteoarthrosis10.1136/ard.36.3.199 ↗
6. Aggrecan, aging and assembly in articular cartilage10.1007/s00018-005-5217-x ↗
7. Function of proteoglycans in the extracellular matrix
8. The ins and outs of aggrecan10.1016/S0962-8924(00)89115-1 ↗
9. The specific interaction of hyaluronic acid with cartilage proteoglycans10.1016/0304-4165(72)90160-2 ↗
10. Buckwalter · J. Biol. Chem. · 1984 · 259 · 536110.1016/S0021-9258(18)91012-4 ↗
11. Biology of intervertebral disc aging and degeneration: involvement of the extracellular matrix10.1097/01.brs.0000146101.53784.b1 ↗
12. The large proteoglycans of the human intervertebral disc-changes in their biosynthesis and structure with age,topography and pathology10.1097/00007632-199503150-00008 ↗
13. Aggrecanases and aggrecanase-generated fragments in the human intervertebral disc at early and advanced stages of disc degeneration10.1097/BRS.0b013e318158cb85 ↗
14. Aggrecan degradation in human intervertebral disc and articular cartilage10.1042/bj3260235 ↗
15. Cell-mediated catabolism of aggrecan evidence that cleavage at the “aggrecanase” site (glu-ala) is a primary event in proteolysis of the interglobular domain10.1074/jbc.270.6.2550 ↗
16. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis10.1172/JCI117907 ↗
17. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints10.1172/JCI119526 ↗
18. Structure, function, aging and turnover of aggrecan in the intervertebral disc
19. Synthetic glycopolymers: an overview10.1016/j.eurpolymj.2003.10.019 ↗
20. Molecular design and syntheses of glycopolymers10.1016/S0079-6700(00)00038-1 ↗
21. Modern trends in polymer bioconjugates design10.1016/j.progpolymsci.2007.07.005 ↗
22. Molecular sugar sticks: cylindrical glycopolymer brushes10.1021/ma0515073 ↗
23. Polymerization of styrene sulfonate ethyl ester by ATRP: synthesis and characterization of macromonomers for Suzuki polycondensation10.1002/macp.200600322 ↗
24. Synthesis and characterization of an aggrecan mimic10.1016/j.actbio.2011.12.029 ↗
25. Incorporation of an aggrecan mimic prevents proteolytic degradation of anisotropic cartilage analogs10.1016/j.actbio.2012.08.041 ↗
26. Biomimetic Aggrecan reduces cartilage extracellular matrix from degradation and lowers catabolic activity in ex vivo and in vivo models10.1002/mabi.201300112 ↗
27. Synthesis and characterization of proteoglycan-mimetic graft copolymers with tunable glycosaminoglycan density10.1021/bm501045k ↗
28. Sarkar · 2011
29. Terminal-end functionalization of chondroitin sulfate for the synthesis of biomimetic proteoglycans10.1016/j.carbpol.2012.05.062 ↗
30. Synthesis of macromolecular mimics of small leucine-rich proteoglycans with a poly (ethylene glycol) core and chondroitin sulphate bristles10.1016/j.carbpol.2017.02.083 ↗
31. Biomimetic proteoglycans mimic macromolecular architecture and water uptake of natural proteoglycans10.1021/acs.biomac.7b00032 ↗
32. Analytical aspects of pharmaceutical grade chondroitin sulfates10.1002/jps.20997 ↗
33. Determination of molecular mass values of chondroitin sulfates by fluorophore-assisted carbohydrate electrophoresis (FACE)10.1016/j.jpba.2009.10.015 ↗
34. Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range10.1126/science.178.4063.871 ↗
35. Proteinpolysaccharide complex from bovine nasal cartilage. The function of glycoprotein in the formation of aggregates10.1016/S0021-9258(19)78236-2 ↗
36. Odian · 2004
37. Advances in bioconjugation10.2174/138527210790069839 ↗
38. Studies on the reaction of fluorescamine with primary amines10.1016/0003-9861(74)90490-1 ↗
39. Rubinstein · 2003
40. Synthesis, characterization and behavior in aqueous solution of star-shaped poly (acrylic acid)10.1002/macp.200500238 ↗
41. Interaction of polyacrylic acid with lipid bilayers: effect of polymer mass10.1002/mrc.4013 ↗
42. NMR chemical shifts in structural biology of glycosaminoglycans10.1021/ac401791h ↗
43. High-resolution proton nuclear magnetic resonance studies on chondroitin sulfates10.2116/analsci.9.53 ↗
44. Colthup · 2012
45. Hydration of polymeric components of cartilage—an infrared spectroscopic study on hyaluronic acid and chondroitin sulfate10.1016/S0141-8130(00)00161-6 ↗
46. Hydration of hyaluronic acid as a function of the counterion type and relative humidity10.1016/0144-8617(95)98837-7 ↗
47. Age-related variation in cell density of human lumbar intervertebral disc10.1097/BRS.0b013e3181cd588c ↗
48. The measurement of fixed charged density in the intervertebral disc10.1016/0304-4165(79)90415-X ↗
49. Cisplatin delivery from poly (acrylic acid-co-methyl methacrylate) microparticles10.1016/j.jconrel.2005.05.005 ↗
50. R. JR. Mechanisms of mucoadhesion of poly (acrylic acid) hydrogels10.1023/A:1016467219657 ↗
51. Long-term in vivo biodistribution imaging and toxicity of polyacrylic acid-coated upconversion nanophosphors10.1016/j.biomaterials.2010.05.065 ↗
52. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage10.1172/JCI114215 ↗
53. A molecular model of proteoglycan-associated electrostatic forces in cartilage mechanics10.1115/1.2796000 ↗
54. An in vivo model of reduced nucleus pulposus glycosaminoglycan content in the rat lumbar intervertebral disc10.1097/BRS.0b013e31816054f8 ↗
55. Measurements of proteoglycan and water content distribution in human lumbar intervertebral discs10.1097/BRS.0b013e318067dd3f ↗
56. Mechanical and biochemical changes in the superficial zone of articular cartilage in canine experimental osteoarthritis10.1002/jor.1100120404 ↗
57. Altered mechanics of cartilage with osteoarthritis: human osteoarthritis and an experimental model of joint degeneration10.1053/joca.1998.0170 ↗
58. Direct measurement of glycosaminoglycan intermolecular interactions via high-resolution force spectroscopy10.1021/ma0121621 ↗
59. Molecular-level theoretical model for electrostatic interactions within polyelectrolyte brushes: applications to charged glycosaminoglycans10.1021/la027001k ↗
60. 23Na TQF NMR imaging for the study of spinal disc tissue10.1016/j.jmr.2008.07.024 ↗
61. Immunolocalisation of type VI collagen in the intervertebral disc10.1136/ard.50.11.787 ↗
62. Topographical variation in the distributions of versican, aggrecan and perlecan in the foetal human spine reflects their diverse functional roles in spinal development10.1007/s00418-009-0623-z ↗
63. Proteoglycan chemistry of the intervertebral disks10.1097/00003086-197711000-00013 ↗
64. Aging and Degeneration of the Human Intervertebral Disc10.1097/00007632-199506000-00022 ↗
65. Swelling pressure of the lumbar intervertebral discs: influence of age, spinal level, composition, and degeneration10.1097/00007632-198802000-00009 ↗
66. Oxygen and lactate concentrations measured in vivo in the intervertebral discs of patients with scoliosis and back pain10.1097/00007632-199801010-00001 ↗
67. Effects of low oxygen concentrations and metabolic inhibitors on proteoglycan and protein synthesis rates in the intervertebral disc10.1002/jor.1100170607 ↗
68. Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators10.1302/0301-620X.84B2.0840196 ↗
69. Toward a biochemical understanding of human intervertebral disc degeneration and herniation: contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases10.1097/00007632-199705150-00003 ↗
70. Effects of aging and degeneration on the human intervertebral disc during the diurnal cycle: a finite element study10.1002/jor.21475 ↗